Business Model

The Company visualizes a strong global presence for demand of its products viz, Guaifenesin, Methocarbamol, Phenazopyridine Hydrochloride, Metformin, Fluconazole, Ambroxol Hcl.

Gennex has acquired a unit ‘Deccan Remedies Limited’ built-up on a land of about 32 acres near Zaheerabad, about 100 kms from Hyderabad where civil construction is almost completed. The unit is expected to go on stream in a year and targeted for a mix of High Volume, Low Value and Low Volume, High Value Active Pharmaceuticals Ingredients. The facility is also being designed to meet the approval of regulatory bodies such as US (FDA), EDQM & TGA. This will help Gennex Laboratories to enhance its turnover to 20 Million US$ when fully operational.

Falma Laboratories Private Limited a sister concern located in Bangalore, is a formulation unit and has a strong export base in African Countries. Gennex is actively pursuing synergizing the activity of converting Guaifenesin and Metformin to PFI’s (Pharmaceutical Formulation Intermediates) for export, which will boost its sales and presence in these markets.